Measuring Type-2 Diabetes Care and Outcomes Across Patients and their Communities
Vizient, Inc. obtained certification from the Centers for Medicaid and Medicare Services (CMS) in 2022 to become a Qualified Entity (QE), allowing us to receive 100% of Medicare claims from all 50 states and the District of Columbia. As part of this certification, Vizient has published its second public report utilizing this data, in combination with other Vizient data resources, to provide measures of provider performance.
The rising prevalence of diabetes presents a significant challenge for both the healthcare system and patients with this complex disease. 11.6% of the US population (38.4 million people) is estimated to have type 1 or type 2 diabetes and 38% of US adults (97.6 million people) have prediabetes1. Each year, an increasing number of patients are facing the financial burden and worse health outcomes associated with diabetes. Meanwhile, hospitals are experiencing mounting pressure due to rising patient acuity and capacity constraints.
Diabetes incidence and prevalence are interconnected with health-related social needs, such as an individual’s housing and food security, education level, economic outlook, access to transportation and healthcare. Healthcare systems are employing strategies to address the social needs of their patient populations. However, the data required to evaluate these efforts is often lacking. This report aims to provide examples of metrics that can be used by hospitals to track efforts to improve diabetes care and outcomes.
The report contains one standard quality measure, the percentage of T2D patients receiving diabetic eye exams annually, categorized by age group and payer.